Mannkind
MannKind entices Lilly VP to CMO role
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical
MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
New chief exec at MannKind
January 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer
The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …
Sanofi abandons MannKind’s failed inhalable insulin
January 6, 2016Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin
Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …
FDA ‘yes’ to inhaled insulin
June 30, 2014Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human
The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …
Inhaled insulin one step closer to approval
April 3, 2014Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2
After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …
Awards recognise top pharma manufacturing projects
January 19, 2010Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer
The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …
Manufacturing news in brief
January 12, 2010Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical
This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …
Mannkind picks up Pfizer’s Exubera facility
March 16, 2009Manufacturing and Production Mannkind, diabetes
The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …
Latest content
